Fox Run Management’s AbbVie ABBV Stock Holding History

Fox Run Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,128	Closed	-$581K	–	873
2025 Q2	$581K	Buy	+3,128	New	+$581K	0.1%	401
2024 Q3	–	Sell	-2,477	Closed	-$425K	–	764
2024 Q2	$425K	Buy	+2,477	New	+$410K	0.08%	468
2024 Q1	–	Sell	-4,025	Closed	-$624K	–	715
2023 Q4	$624K	Buy	4,025 +2,471	+159%	+$360K	0.16%	218
2023 Q3	$232K	Sell	1,554 -4,681	-75%	-$687K	0.07%	520
2023 Q2	$840K	Buy	+6,235	New	+$914K	0.24%	128
2022 Q2	–	Sell	-2,137	Closed	-$346K	–	490
2022 Q1	$346K	Buy	+2,137	New	+$310K	0.19%	214
2021 Q4	–	Sell	-3,603	Closed	-$389K	–	442
2021 Q3	$389K	Buy	+3,603	New	+$412K	0.25%	146
2019 Q3	–	Sell	-5,030	Closed	-$366K	–	340
2019 Q2	$366K	Buy	+5,030	New	+$395K	0.24%	155
2018 Q3	–	Sell	-9,734	Closed	-$902K	–	538
2018 Q2	$902K	Buy	9,734 +4,878	+100%	+$476K	0.29%	51
2018 Q1	$460K	Buy	+4,856	New	+$533K	0.11%	339
2017 Q2	–	Sell	-4,800	Closed	-$313K	–	609
2017 Q1	$313K	Buy	+4,800	New	+$302K	0.13%	356
2016 Q3	–	Sell	-7,700	Closed	-$477K	–	467
2016 Q2	$477K	Buy	+7,700	New	+$469K	0.23%	143
2016 Q1	–	Sell	-9,800	Closed	-$581K	–	394
2015 Q4	$581K	Buy	+9,800	New	+$564K	0.45%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fox Run Management's ABBV Position: Q3 2025 in Review

Fox Run Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 3,128 shares — an estimated $581K sold.

Fox Run Management first reported a position in ABBV in Q4 2015 and held it in 13 quarters. The position peaked at $902K in Q2 2018. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Fox Run Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Fox Run Management sold 3,128 AbbVie shares in Q3 2025, an estimated $581K.
Fox Run Management first reported a position in AbbVie in Q4 2015 and held it in 13 quarters.
Fox Run Management's AbbVie position peaked at $902K in Q2 2018.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.